171 related articles for article (PubMed ID: 1692265)
1. Analysis of styrene oxide-globin adducts based upon reaction with Raney nickel.
Ting D; Smith MT; Doane-Setzer P; Rappaport SM
Carcinogenesis; 1990 May; 11(5):755-60. PubMed ID: 1692265
[TBL] [Abstract][Full Text] [Related]
2. Application of Raney nickel to measure adducts of styrene oxide with hemoglobin and albumin.
Rappaport SM; Ting D; Jin Z; Yeowell-O'Connell K; Waidyanatha S; McDonald T
Chem Res Toxicol; 1993; 6(2):238-44. PubMed ID: 7682851
[TBL] [Abstract][Full Text] [Related]
3. Albumin and hemoglobin adducts as biomarkers of exposure to styrene in fiberglass-reinforced-plastics workers.
Fustinoni S; Colosio C; Colombi A; Lastrucci L; Yeowell-O'Connell K; Rappaport SM
Int Arch Occup Environ Health; 1998 Feb; 71(1):35-41. PubMed ID: 9523247
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of exposure to styrene oxide by GC-MS analysis of phenylhydroxyethyl esters in hemoglobin.
Sepai O; Anderson D; Street B; Bird I; Farmer PB; Bailey E
Arch Toxicol; 1993; 67(1):28-33. PubMed ID: 8452476
[TBL] [Abstract][Full Text] [Related]
5. Determination of albumin and hemoglobin adducts in workers exposed to styrene and styrene oxide.
Yeowell-O'Connell K; Jin Z; Rappaport SM
Cancer Epidemiol Biomarkers Prev; 1996 Mar; 5(3):205-15. PubMed ID: 8833621
[TBL] [Abstract][Full Text] [Related]
6. Hydrolytic Cleavage Products of Globin Adducts in Urine as Possible Biomarkers of Cumulative Dose: Proof of Concept Using Styrene Oxide as a Model Adduct-Forming Compound.
Mráz J; Hanzlíková I; Moulisová A; Dušková Š; Hejl K; Bednářová A; Dabrowská L; Linhart I
Chem Res Toxicol; 2016 Apr; 29(4):676-86. PubMed ID: 26954110
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and characterization of styrene oxide adducts with cysteine, histidine, and lysine in human globin.
Jágr M; Mráz J; Linhart I; Stránský V; Pospísil M
Chem Res Toxicol; 2007 Oct; 20(10):1442-52. PubMed ID: 17867648
[TBL] [Abstract][Full Text] [Related]
8. Dosimetry of styrene 7,8-oxide in styrene- and styrene oxide-exposed mice and rats by quantification of haemoglobin adducts.
Osterman-Golkar S; Christakopoulos A; Zorcec V; Svensson K
Chem Biol Interact; 1995 Mar; 95(1-2):79-87. PubMed ID: 7697755
[TBL] [Abstract][Full Text] [Related]
9. Comparison of styrene-7,8-oxide adducts formed via reaction with cysteine, N-terminal valine and carboxylic acid residues in human, mouse and rat hemoglobin.
Yeowell-O'Connell K; Pauwels W; Severi M; Jin Z; Walker MR; Rappaport SM; Veulemans H
Chem Biol Interact; 1997 Aug; 106(1):67-85. PubMed ID: 9305409
[TBL] [Abstract][Full Text] [Related]
10. Protein adducts as dosimeters of human exposure to styrene, styrene-7,8-oxide, and benzene.
Rappaport SM; Yeowell-O'Connell K
Toxicol Lett; 1999 Sep; 108(2-3):117-26. PubMed ID: 10511253
[TBL] [Abstract][Full Text] [Related]
11. Ring test for the determination of N-terminal valine adducts of styrene 7,8-oxide with haemoglobin by the modified Edman degradation technique.
Pauwels W; Farmer PB; Osterman-Golkar S; Severi M; Cordero R; Bailey E; Veulemans H
J Chromatogr B Biomed Sci Appl; 1997 Nov; 702(1-2):77-83. PubMed ID: 9449558
[TBL] [Abstract][Full Text] [Related]
12. Biological fate of styrene oxide adducts with globin: Elimination of cleavage products in the rat urine.
Mráz J; Hanzlíková I; Dušková Š; Dabrowská L; Chrástecká H; Vajtrová R; Linhart I
Toxicol Lett; 2016 Nov; 261():26-31. PubMed ID: 27575569
[TBL] [Abstract][Full Text] [Related]
13. 1,3-butadiene: cancer, mutations, and adducts. Part V: Hemoglobin adducts as biomarkers of 1,3-butadiene exposure and metabolism.
Swenberg JA; Christova-Gueorguieva NI; Upton PB; Ranasinghe A; Scheller N; Wu KY; Yen TY; Hayes R
Res Rep Health Eff Inst; 2000 Mar; (92):191-210; discussion 211-9. PubMed ID: 10925842
[TBL] [Abstract][Full Text] [Related]
14. Styrene oxide in blood, hemoglobin adducts, and urinary metabolites in human volunteers exposed to (13)C(8)-styrene vapors.
Johanson G; Ernstgård L; Gullstrand E; Löf A; Osterman-Golkar S; Williams CC; Sumner SC
Toxicol Appl Pharmacol; 2000 Oct; 168(1):36-49. PubMed ID: 11000098
[TBL] [Abstract][Full Text] [Related]
15. O6-substituted-2'-deoxyguanosine-3'-phosphate adducts detected by 32P post-labeling of styrene oxide treated DNA.
Pongracz K; Kaur S; Burlingame AL; Bodell WJ
Carcinogenesis; 1989 Jun; 10(6):1009-13. PubMed ID: 2720897
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of styrene oxide in the rat and guinea pig.
Nakatsu K; Hugenroth S; Sheng LS; Horning EC; Horning MG
Drug Metab Dispos; 1983; 11(5):463-70. PubMed ID: 6138232
[TBL] [Abstract][Full Text] [Related]
17. Investigation of protein-styrene oxide adducts as a molecular biomarker of human exposed to styrene.
Liu SF; Fang QM; Jin ZL; Rappaport MS
J Environ Sci (China); 2001 Oct; 13(4):391-7. PubMed ID: 11723921
[TBL] [Abstract][Full Text] [Related]
18. Evidence for DNA and protein binding by styrene and styrene oxide.
Phillips DH; Farmer PB
Crit Rev Toxicol; 1994; 24 Suppl():S35-46. PubMed ID: 7818770
[TBL] [Abstract][Full Text] [Related]
19. Investigation of styrene oxide-DNA adducts and their detection in workers exposed to styrene.
Bodell WJ; Pongracz K; Kaur S; Burlingame AL; Liu SF; Rappaport SM
Prog Clin Biol Res; 1990; 340C():271-82. PubMed ID: 2381929
[No Abstract] [Full Text] [Related]
20. Differential distribution of 4-hydroxynonenal adducts to sulfur and nitrogen residues in blood proteins as revealed using Raney nickel and gas chromatography-mass spectrometry.
Lesgards JF; Frayne IR; Comte B; Busseuil D; Rhéaume E; Tardif JC; Rosiers CD
Free Radic Biol Med; 2009 Nov; 47(10):1375-85. PubMed ID: 19682568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
